3Friedman HS,Bigner DD.Glioblastoma multiforme and the epidermal growth factor receptor.N Engl J Med,2005,353(19):1997-1999.
4Van den Bent MJ,Brandes AA,Rampling R,et al.Randomized phase Ⅱ trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma:EORTC brain tumor group study 26034.J Clin Oncol,2009,27(8):1268-1274.
5Groot GF,Gilbert M,Aldape K,et al.Phase Ⅱ study of carboplatin and erlotinib (Tarceva,OSI-774) in patients with recurrent glioblastoma.J Neurooncol,2008,90(1):89-97.
6Lo HW,Cao X,Zhu H,et al.Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in highgrade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.Clin Cancer Res,2008,14(19):6042-6054.
7Sathornsumetee S,Vredenburgh JJ,Rich JN,et al.Phase Ⅱ study of bevacizumab and erlotinib in patients with recurrent glioblastoma multiforme.J Clin Oncol,2008,26(15):13008.
8Robins HI,Wen PY,Chang SM,et al.Phase Ⅰ study of erlotinib and CCI-779 (temsirolimus) for patients with reurrent malignant gliomas (MG) (NABTC 04-02).J Clin Oncol,2007,25(18):2057.
9Prados MD,Chang SM,Butowski N,et al.Phase Ⅱ study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.J Clin Oncol,2009,27(4):579-684.
10Halatsch ME,Low S,Hielscher T,et al.Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib.Anticancer Res,2008,28 (6):3725-3728.
